Publications
519 results found
Sandy CJ, Taylor G, Steiger M, et al., 1996, HTLV-I associated uveitis: A report of two cases, EYE, Vol: 10, Pages: 521-522, ISSN: 0950-222X
- Author Web Link
- Cite
- Citations: 5
Goubau P, Wantzin P, Gessain A, et al., 1996, Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe, JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, Vol: 13, Pages: 68-77, ISSN: 1077-9450
- Author Web Link
- Cite
- Citations: 85
Taylor GP, 1996, The epidemiology of HTLV-I in Europe., J Acquir Immune Defic Syndr Hum Retrovirol, Vol: 13 Suppl 1, Pages: S8-14, ISSN: 1077-9450
Although human T-lymphotropic virus type I (HTLV-I) infection in Europe is thought to be unusual except amongst people who have immigrated from countries where HTLV-I is endemic, the screening of blood donors has revealed a low seroprevalence across Europe, not only in donors originating from endemic areas but also in the indigenous population. Data from blood donors should not be extrapolated to other groups because blood donors are selected to be at low risk of parenterally transmissible infections. Unfortunately only small studies have been conducted in other population groups, including women attending antenatal clinics, despite the importance of breast-feeding in vertical transmission. Data from metropolitan areas of the United Kingdom and France suggest that the seroprevalence of HTLV-I in pregnant women is up to 100 times higher than in blood donors. HTLV-I infection is also more common in patients attending sexually transmitted disease clinics, whilst HTLV-II is endemic in many cities amongst intravenous drug users. There are few incidence data for diseases associated with HTLV-I, even though cases of adult T-cell leukemia/lymphoma and HTLV-I-associated myelopathy have been described in many European countries. Data on the seroprevalence of HTLV-I in central and eastern Europe are scanty but the few published studies suggest a higher rate than has been documented in western Europe.
TAYLOR GP, TOSSWILL JHC, MATUTES E, et al., 1995, LONGITUDINAL PROSPECTIVE-STUDY OF HTLV-I INFECTION IN HEALTH AND DISEASE - VIROLOGICAL AND IMMUNOLOGICAL PARAMETERS, JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, Vol: 10, Pages: 196-196, ISSN: 1077-9450
ALI M, RETHWILM A, CHEINGSONGPOPOV R, et al., 1995, SEROEPIDEMIOLOGY OF HFV INFECTION, JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, Vol: 10, Pages: 239-239, ISSN: 1077-9450
NIEWIESK S, DAENKE S, PARKER CE, et al., 1995, NATURALLY-OCCURRING VARIANTS OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I TAX PROTEIN IMPAIR ITS RECOGNITION BY CYTOTOXIC T-LYMPHOCYTES AND THE TRANSACTIVATION FUNCTION OF TAX, JOURNAL OF VIROLOGY, Vol: 69, Pages: 2649-2653, ISSN: 0022-538X
- Author Web Link
- Cite
- Citations: 93
Niewiesk S, Daenke S, Parker CE, et al., 1994, Naturally occurring variants of HTLV-I tax protein impair its recognition by CTL and the transactivation function of Tax., Journal of Virology, Vol: 69, Pages: 2649-2653, ISSN: 1098-5514
NIEWIESK S, DAENKE S, PARKER CE, et al., 1994, THE TRANSACTIVATOR GENE OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I IS MORE VARIABLE WITHIN AND BETWEEN HEALTHY CARRIERS THAN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS, JOURNAL OF VIROLOGY, Vol: 68, Pages: 6778-6781, ISSN: 0022-538X
- Author Web Link
- Cite
- Citations: 83
PARKER CE, NIGHTINGALE S, TAYLOR GP, et al., 1994, CIRCULATING ANTI-TAX CYTOTOXIC T-LYMPHOCYTES FROM HUMAN T-CELL LEUKEMIA-VIRUS TYPE I-INFECTED PEOPLE, WITH AND WITHOUT TROPICAL SPASTIC PARAPARESIS, RECOGNIZE MULTIPLE EPITOPES SIMULTANEOUSLY, JOURNAL OF VIROLOGY, Vol: 68, Pages: 2860-2868, ISSN: 0022-538X
- Author Web Link
- Cite
- Citations: 107
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.